MedTrace Logo

Impact Study of Cholera Vaccination in Endemic Areas - Seroprevalence

NCT05829772 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7000

Last updated 2024-09-19

No results posted yet for this study

Summary

This project aims to fill this essential knowledge gap by assessing the impact of oral cholera vaccine mass campaigns in 2 sites (urban and rural) in DRC, described in this protocol. The evidence generated from this project will be key to develop future strategies regarding cholera vaccine use in endemic settings, including places with higher burden in terms of cholera mortality

Conditions

  • Cholera

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER

  • Institut Pasteur

    collaborator INDUSTRY

  • Institut National de Recherche Biomédicale. Goma, République Démocratique du Congo

    collaborator UNKNOWN

  • Ministry of Public Health, Democratic Republic of the Congo

    collaborator OTHER_GOV

  • Medecins Sans Frontieres, France

    collaborator UNKNOWN

  • Epicentre

    lead OTHER

Principal Investigators

  • Klaudia Porten · Epicentre

  • Francisco Luquero · Gavi

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-20
Primary Completion
2024-03-31
Completion
2024-04-01

Countries

  • Democratic Republic of the Congo

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05829772 on ClinicalTrials.gov